TY - JOUR
T1 - Arachidonic acid and lipoxygenase products stimulate protein kinase Cβ mRNA levels in pituitary αT3-1 cell line
T2 - Role in gonadotropin-releasing hormone action
AU - Shraga-Levine, Zurit
AU - Ben-Menahem, David
AU - Naor, Zvi
PY - 1996/6/1
Y1 - 1996/6/1
N2 - The cross-talk of arachidonic acid (AA) and its lipoxygenase products with protein kinase Cβ (PKCβ) mRNA levels during the action of gonadotropin-releasing hormone (GnRH) was investigated in the pituitary αT3-1 cell line. The addition of AA or its 5-lipoxygenase products 5-hydroxyeicosatetraenoic acid (5-HETE) or leukotriene C4 (LTC4) for 30 or 60 min stimulated PCKβ, but not PKCα mRNA levels (3-5-fold); PCKγ is not expressed by the cells. Other HETEs or leukotrienes tested showed no significant effect. The range of effective concentration for LTC, and 5-HETE (around 10-10 M) is the range found in GnRH-stimulated pituitary cells. Although PKCβ mRNA levels were preferentially elevated by LTC4 and 5-HETE at early time points, PKCα mRNA levels were elevated at 6-12 h of incubation when PKCβ mRNA levels returned to basal levels. The addition of the phospholipase A2 inhibitor 4-bromophenacyl bromide or the selective 5-lipoxygenase inhibitor L-656,224 abolished [D-Trp6]GnRH (GnRH-A) elevation of PKCβ mRNA levels, whereas PKCα mRNA levels were not increased by this neurohormone. The cyclo-oxygenase inhibitor indomethacin elevated basal PKCβ mRNA levels and potentiated the GnRH-A response. Cross-talk exists between AA and some of its lipoxygenase products and PKCβ gene expression during cell signalling. AA, 5-HETE and LTC4 participate in the rapid stimulation of PKCβ mRNA levels by GnRH.
AB - The cross-talk of arachidonic acid (AA) and its lipoxygenase products with protein kinase Cβ (PKCβ) mRNA levels during the action of gonadotropin-releasing hormone (GnRH) was investigated in the pituitary αT3-1 cell line. The addition of AA or its 5-lipoxygenase products 5-hydroxyeicosatetraenoic acid (5-HETE) or leukotriene C4 (LTC4) for 30 or 60 min stimulated PCKβ, but not PKCα mRNA levels (3-5-fold); PCKγ is not expressed by the cells. Other HETEs or leukotrienes tested showed no significant effect. The range of effective concentration for LTC, and 5-HETE (around 10-10 M) is the range found in GnRH-stimulated pituitary cells. Although PKCβ mRNA levels were preferentially elevated by LTC4 and 5-HETE at early time points, PKCα mRNA levels were elevated at 6-12 h of incubation when PKCβ mRNA levels returned to basal levels. The addition of the phospholipase A2 inhibitor 4-bromophenacyl bromide or the selective 5-lipoxygenase inhibitor L-656,224 abolished [D-Trp6]GnRH (GnRH-A) elevation of PKCβ mRNA levels, whereas PKCα mRNA levels were not increased by this neurohormone. The cyclo-oxygenase inhibitor indomethacin elevated basal PKCβ mRNA levels and potentiated the GnRH-A response. Cross-talk exists between AA and some of its lipoxygenase products and PKCβ gene expression during cell signalling. AA, 5-HETE and LTC4 participate in the rapid stimulation of PKCβ mRNA levels by GnRH.
UR - http://www.scopus.com/inward/record.url?scp=0029982726&partnerID=8YFLogxK
U2 - 10.1042/bj3160667
DO - 10.1042/bj3160667
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
AN - SCOPUS:0029982726
SN - 0264-6021
VL - 316
SP - 667
EP - 670
JO - Biochemical Journal
JF - Biochemical Journal
IS - 2
ER -